Position history for ALPS ADVISORS INC's holdings in Catalyst Pharmaceuticals Inc
ALPS ADVISORS INC holds 21,317 shares of CPRX (Catalyst Pharmaceuticals Inc), worth $527,809 as of 2026-Q1. The position was decreased (-7.5% shares). CPRX represents 0.0% of ALPS ADVISORS INC's portfolio.
Current Value
$527,809
Current Shares
21,317
Total Value Change
+$195,254
Total Shares Change
-152
Other major holders of CPRX: BlackRock, Inc.
Decreased |
| 21,317 |
-7.5% |
| $527,809 |
| 0.0% |
| $23.92 |
0 |
| 2025-Q4 | Increased | 23,032 | +0.9% | $537,567 | 0.0% | $23.29 | 24 |
| 2025-Q3 | Increased | 22,832 | +36.9% | $449,790 | 0.0% | $19.55 | 31 |
| 2025-Q2 | Increased | 16,678 | +1.2% | $361,913 | 0.0% | $21.78 | 24 |
| 2025-Q1 | Decreased | 16,476 | -3.7% | $399,543 | 0.0% | $24.69 | 0 |
| 2024-Q4 | Decreased | 17,109 | -2.3% | $357,065 | 0.0% | $21.07 | 0 |
| 2024-Q3 | Decreased | 17,509 | -18.4% | $348,079 | 0.0% | $19.56 | 0 |
| 2024-Q2 | Decreased | 21,469 | -79.5% | $332,555 | 0.0% | $15.49 | 0 |